Data / Form D filings / Bionik Laboratories Corp.
Bionik Laboratories Corp.: Form D filings
Bionik Laboratories Corp., a health care company in Toronto, Ontario, Canada, filed 5 Form D notices with the SEC between 2015 and 2017. The latest, on July 12, 2017, reports $1.3 million sold of a $5.6 million offering to 51 investors.
Find out what Bionik Laboratories Corp. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 483 BAY STREET, N105, Toronto, Ontario, Canada, M5G2C
- Phone
- 1.416.640.7887
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1508381
The full lists. Form D filings in Other Health Care: 1,958 rows, $97.90, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 12, 2017 | New notice | $5,644,238 | $1,250,043 | $4,394,195 | 51 | Jun 27, 2017 | sec.gov |
| May 2, 2016 | New notice | $26,961,000 | $26,961,000 | $0 | 78 | Apr 21, 2016 | sec.gov |
| Jul 14, 2015 | Amendment | $15,400,000 | $13,126,600 | $2,273,400 | 162 | Feb 26, 2015 | sec.gov |
| May 6, 2015 | Amendment | $12,800,000 | $10,363,600 | $2,436,400 | 122 | Feb 26, 2015 | sec.gov |
| Mar 12, 2015 | New notice | $12,800,000 | $6,188,600 | $6,611,400 | 76 | Feb 26, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Peter Bloch | Executive Officer, Director | |
| Marc Mathieu | Director | |
| Leslie Markow | Executive Officer | |
| Robert Hariri | Director | |
| Hermano Igo Krebs | Director | |
| Timothy McCarthy | Executive Officer | |
| Michal Prywata | Executive Officer, Director |
Every Form D from the week of Jul 10, 2017 · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Bionik Laboratories Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.